Janus Henderson Group
MCRB icon

Janus Henderson Group’s Seres Therapeutics MCRB Stock Holding History

Janus Henderson Group’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-140,677
Closed -$6.7M – 2583
2023
Q3 		$6.7M Sell
140,677
-162,970
-54% -$12.4M ﹤0.01% 752
2023
Q2 		$29.1M Sell
303,647
-261,394
-46% -$28.4M 0.02% 497
2023
Q1 		$64.1M Buy
565,041
+2,626
+0.5% +$284K 0.04% 328
2022
Q4 		$63M Sell
562,415
-553,910
-50% -$74.3M 0.05% 325
2022
Q3 		$143M Buy
1,116,325
+847,805
+316% +$86.8M 0.05% 289
2022
Q2 		$18.4M Sell
268,520
-21,814
-8% -$1.88M 0.01% 582
2022
Q1 		$41.3M Buy
290,334
+37,579
+15% +$5.78M 0.02% 552
2021
Q4 		$42.1M Buy
252,755
+35,815
+17% +$5.69M 0.02% 601
2021
Q3 		$30.2M Buy
216,940
+26,653
+14% +$5.22M 0.01% 691
2021
Q2 		$90.8M Buy
190,287
+7,890
+4% +$3.33M 0.04% 398
2021
Q1 		$75.1M Buy
182,397
+50,133
+38% +$23.1M 0.03% 443
2020
Q4 		$64.8M Buy
132,264
+36,560
+38% +$21.4M 0.03% 475
2020
Q3 		$54.2M Buy
+95,704
New +$31.8M 0.03% 480

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group's MCRB Position: Q4 2023 in Review

Janus Henderson Group sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 140,677 shares — an estimated $6.7M sold.

Janus Henderson Group first reported a position in MCRB in Q3 2020 and held it in 13 quarters. The position peaked at $143M in Q3 2022. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.

  • Janus Henderson Group reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Janus Henderson Group sold 140,677 Seres Therapeutics shares in Q4 2023, an estimated $6.7M.
  • Janus Henderson Group first reported a position in Seres Therapeutics in Q3 2020 and held it in 13 quarters.
  • Janus Henderson Group's Seres Therapeutics position peaked at $143M in Q3 2022.
  • 102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.

Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.